• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤立性低高密度脂蛋白胆固醇是心血管疾病的危险因素吗?弗雷明汉后代研究的新见解。

Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.

作者信息

Bartlett Jacquelaine, Predazzi Irene M, Williams Scott M, Bush William S, Kim Yeunjung, Havas Stephen, Toth Peter P, Fazio Sergio, Miller Michael

机构信息

Department of Genetics, Geisel School of Medicine, Dartmouth College, Hanover, NH.

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.

出版信息

Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10.

DOI:10.1161/CIRCOUTCOMES.115.002436
PMID:27166203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4871717/
Abstract

BACKGROUND

Although the inverse association between high-density lipoprotein cholesterol (HDL-C) and risk of cardiovascular disease (CVD) has been long established, it remains unclear whether low HDL-C remains a CVD risk factor when levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) are not elevated. This is a timely issue because recent studies have questioned whether HDL-C is truly an independent predictor of CVD.

METHODS AND RESULTS

3590 men and women from the Framingham Heart Study offspring cohort without known CVD were followed between 1987 and 2011. Low HDL-C (<40 mg/dL in men and <50 mg/dL in women) was defined as isolated if TG and LDL-C were both low (<100 mg/dL). We also examined higher thresholds for TG (150 mg/dL) and LDL-C (130 mg/dL) and compared low versus high HDL-C phenotypes using logistic regression analysis to assess association with CVD. Compared with isolated low HDL-C, CVD risks were higher when low HDL-C was accompanied by LDL-C ≥100 mg/dL and TG <100 mg/dL (odds ratio 1.3 [1.0, 1.6]), TG ≥100 mg/dL and LDL-C <100 mg/dL (odds ratio 1.3 [1.1, 1.5]), or TG and LDL-C ≥100 mg/dL (odds ratio 1.6, [1.2, 2.2]), after adjustment for covariates. When low HDL-C was analyzed with higher thresholds for TG (≥150 mg/dL) and LDL-C (≥130 mg/dL), results were essentially the same. In contrast, compared with isolated low HDL-C, high HDL-C was associated with 20% to 40% lower CVD risk except when TG and LDL-C were elevated.

CONCLUSIONS

CVD risk as a function of HDL-C phenotypes is modulated by other components of the lipid panel.

摘要

背景

尽管高密度脂蛋白胆固醇(HDL-C)与心血管疾病(CVD)风险之间的负相关关系早已确立,但当低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)水平未升高时,低HDL-C是否仍是CVD风险因素仍不清楚。这是一个及时的问题,因为最近的研究对HDL-C是否真的是CVD的独立预测因子提出了质疑。

方法与结果

对弗雷明汉心脏研究后代队列中3590名无已知CVD的男性和女性在1987年至2011年期间进行了随访。如果TG和LDL-C均低(<100mg/dL),则将低HDL-C(男性<40mg/dL,女性<50mg/dL)定义为孤立性低HDL-C。我们还检查了TG(150mg/dL)和LDL-C(130mg/dL)的更高阈值,并使用逻辑回归分析比较低HDL-C与高HDL-C表型,以评估与CVD的关联。与孤立性低HDL-C相比,当低HDL-C伴有LDL-C≥100mg/dL且TG<100mg/dL(比值比1.3 [1.0, 1.6])、TG≥100mg/dL且LDL-C<100mg/dL(比值比1.3 [1.1, 1.5])或TG和LDL-C≥100mg/dL(比值比1.6, [1.2, 2.2])时,调整协变量后CVD风险更高。当以TG(≥150mg/dL)和LDL-C(≥130mg/dL)的更高阈值分析低HDL-C时,结果基本相同。相比之下,与孤立性低HDL-C相比,高HDL-C与CVD风险降低20%至40%相关,但TG和LDL-C升高时除外。

结论

作为HDL-C表型函数的CVD风险受血脂谱其他成分的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a035/4871717/ba82430cb072/nihms-778537-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a035/4871717/ba82430cb072/nihms-778537-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a035/4871717/ba82430cb072/nihms-778537-f0001.jpg

相似文献

1
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.孤立性低高密度脂蛋白胆固醇是心血管疾病的危险因素吗?弗雷明汉后代研究的新见解。
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10.
2
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.弗雷明汉心脏研究中一系列不良主要血浆脂质组合的心血管事件长期风险。
Am Heart J. 2014 Dec;168(6):878-83.e1. doi: 10.1016/j.ahj.2014.08.007. Epub 2014 Sep 16.
3
Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.高心血管风险患者血脂水平达标情况:来自英国、瑞典、西班牙和加拿大的观察性研究的汇总分析。
Eur J Intern Med. 2013 Oct;24(7):656-63. doi: 10.1016/j.ejim.2013.07.005. Epub 2013 Aug 13.
4
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常:2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
5
Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.老年人的血脂谱及其与心血管疾病的关系:PREV-ICTUS研究
Curr Med Res Opin. 2008 Mar;24(3):659-70. doi: 10.1185/030079908X273372. Epub 2008 Jan 23.
6
Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.成人生命历程中血脂浓度的变化轨迹与心血管疾病和全因死亡率的风险:弗雷明汉研究 35 年来的观察结果。
J Am Heart Assoc. 2019 Jun 4;8(11):e011433. doi: 10.1161/JAHA.118.011433. Epub 2019 May 29.
7
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.高密度脂蛋白胆固醇极端水平下的脂质表型:脂质-9超大型数据库
J Clin Lipidol. 2015 Jul-Aug;9(4):511-8.e1-5. doi: 10.1016/j.jacl.2015.05.005. Epub 2015 Jun 19.
8
Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.血脂谱的分层建模与10年(2002 - 2012年)全因死亡率及心血管疾病发病率:阿提卡研究
Lipids Health Dis. 2015 Sep 15;14:108. doi: 10.1186/s12944-015-0101-7.
9
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.在 10 年发生动脉粥样硬化性心血管疾病风险低的个体中,低密度脂蛋白胆固醇与心血管死亡率的长期关联。
Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.
10
Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.美国脂质异常的流行情况:2003-2006 年国家健康和营养调查。
J Clin Lipidol. 2012 Jul-Aug;6(4):325-30. doi: 10.1016/j.jacl.2012.05.002. Epub 2012 May 22.

引用本文的文献

1
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白,第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
2
Development and validation of nomograms including individual- and area-level variables to predict risk of fatal and non-fatal cardiovascular diseases among Russian population.包含个体和地区层面变量的列线图的开发与验证,用于预测俄罗斯人群中致命和非致命心血管疾病的风险。
PLoS One. 2025 Jun 2;20(5):e0324736. doi: 10.1371/journal.pone.0324736. eCollection 2025.
3

本文引用的文献

1
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.清道夫受体BI中的罕见变异会升高高密度脂蛋白胆固醇并增加冠心病风险。
Science. 2016 Mar 11;351(6278):1166-71. doi: 10.1126/science.aad3517.
2
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.血管生成素样蛋白4、脂蛋白脂肪酶和富含半胱氨酸的血管内皮细胞生长因子样蛋白1的编码变异与冠心病风险
N Engl J Med. 2016 Mar 24;374(12):1134-44. doi: 10.1056/NEJMoa1507652. Epub 2016 Mar 2.
3
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
Inverted V-shaped association between atherogenic index of plasma and kidney stone risk: results from NHANES 2011-2018.
血浆致动脉粥样硬化指数与肾结石风险之间的倒V形关联:2011 - 2018年美国国家健康与营养检查调查结果
Transl Androl Urol. 2025 Apr 30;14(4):953-963. doi: 10.21037/tau-24-605. Epub 2025 Apr 27.
4
Exploring Cardiovascular Health: The Role of Dyslipidemia and Inflammation.探索心血管健康:血脂异常与炎症的作用。
Cureus. 2025 Feb 10;17(2):e78818. doi: 10.7759/cureus.78818. eCollection 2025 Feb.
5
Independent Association of Individual Lipid Abnormalities with Cardiovascular All-cause Mortality: A Prospective Cohort Study.个体脂质异常与心血管全因死亡率的独立关联:一项前瞻性队列研究。
High Blood Press Cardiovasc Prev. 2025 Jan;32(1):107-119. doi: 10.1007/s40292-024-00694-6. Epub 2024 Dec 9.
6
Association between Atherogenic Dyslipidemia and Subclinical Myocardial Injury in the General Population.普通人群中致动脉粥样硬化性血脂异常与亚临床心肌损伤的关联。
J Clin Med. 2024 Aug 22;13(16):4946. doi: 10.3390/jcm13164946.
7
A Healthy Dietary Pattern May Have a Protective Effect Against Cardiovascular Disease Through Its Interaction With the MC4R Gene Polymorphism.一种健康的饮食模式可能通过其与黑皮质素4受体(MC4R)基因多态性的相互作用对心血管疾病具有保护作用。
Clin Nutr Res. 2024 Jul 26;13(3):214-225. doi: 10.7762/cnr.2024.13.3.214. eCollection 2024 Jul.
8
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function.他汀类药物、依折麦布、PCSK9 抑制剂、Inclisiran 和icosapent ethyl 对血小板功能的影响。
Int J Mol Sci. 2023 Jul 21;24(14):11739. doi: 10.3390/ijms241411739.
9
Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?鱼类来源的ω-3脂肪酸:高密度脂蛋白的守护者?
J Atheroscler Thromb. 2023 Aug 1;30(8):855-858. doi: 10.5551/jat.ED231. Epub 2023 Apr 9.
10
The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review.有氧运动对高密度脂蛋白数量和质量的影响:一项叙述性综述。
Int J Mol Sci. 2023 Feb 28;24(5):4653. doi: 10.3390/ijms24054653.
血管生成素样蛋白4的失活变异与冠状动脉疾病风险
N Engl J Med. 2016 Mar 24;374(12):1123-33. doi: 10.1056/NEJMoa1510926. Epub 2016 Mar 2.
4
Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.空腹甘油三酯可预测他汀类药物治疗的急性冠脉综合征患者的复发性缺血事件。
J Am Coll Cardiol. 2015 Jun 2;65(21):2267-75. doi: 10.1016/j.jacc.2015.03.544.
5
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.载脂蛋白 C-III 与甘油三酯:在动脉粥样硬化性心血管疾病中的关联、机制和治疗靶点
J Am Coll Cardiol. 2014 Dec 16;64(23):2525-40. doi: 10.1016/j.jacc.2014.09.042.
6
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.高密度脂蛋白靶向药物治疗烟酸、贝特类药物和胆固醇酯转运蛋白抑制剂对心血管风险的影响:纳入117411例患者的随机对照试验的荟萃分析
BMJ. 2014 Jul 18;349:g4379. doi: 10.1136/bmj.g4379.
7
Effects of extended-release niacin with laropiprant in high-risk patients.烟酸缓释剂联合拉罗匹仑在高危患者中的作用。
N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955.
8
Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.载脂蛋白 C3 基因失活突变与缺血性血管疾病风险
N Engl J Med. 2014 Jul 3;371(1):32-41. doi: 10.1056/NEJMoa1308027. Epub 2014 Jun 18.
9
Loss-of-function mutations in APOC3, triglycerides, and coronary disease.载脂蛋白 C3 功能丧失突变与甘油三酯和冠心病。
N Engl J Med. 2014 Jul 3;371(1):22-31. doi: 10.1056/NEJMoa1307095. Epub 2014 Jun 18.
10
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality.新兴疗法提高高密度脂蛋白胆固醇(HDL-C)并增强 HDL 颗粒功能。
Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):453-61. doi: 10.1016/j.beem.2013.11.001. Epub 2013 Nov 15.